DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Medical - Instruments & Supplies

Healthcare
$8.52 +1.84%

+$0.19 today

Market cap
$1.70B
Beta
0.91
P/E (TTM)
-3.3
EPS (TTM)
-$3.14
Dividend yield
6.27%
52W Low $9.41High $17.09

Volume 5.40M

Average 4.70M

XRAY Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

DENTSPLY SIRONA Inc.NASDAQ: XRAY

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin narrows to -1.1%

Net margin was -1.1% in Q1 FY2026, down 3.4 pp from a year earlier. On a trailing-twelve-month basis it was -17.1%, up 7.4 pp year over year. Over 3 fiscal years it widened by 8.0 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 12 analysts of 7.7% for the fiscal year ending Dec 2026, up from -16.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-1.1%+14.1 pp QoQ
Last fiscal yearDec 2025
-16.3%+7.7 pp YoY
LTMMar 2026
-17.1%+7.4 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.4 pp+12.6 pp+16.0 pp
1 year+7.7 pp+24.0 pp+16.2 pp
3 years+8.0 pp+23.7 pp+15.7 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-16.3%
Year-over-year change
+7.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How XRAY compares with its peers on the latest reported figures

  • XRAY's LTM Mar 2026 net margin of -17.1% is the lowest of the 4 companies compared; the peer median is 10.0%.
  • Its year-over-year change of +7.4 pp is the 2nd highest of 4, against a peer median of -0.1 pp.
  • Over three fiscal years its change of +8.0 pp compares with a peer median of -1.2 pp.
XRAY Competitors Peer median
Net Margin for XRAY and competitors
Company Period LTM level YoY 3-year change
NVSTEnvista Holdings CorpLTM Oct 202622.0% +21.4 pp-7.7 pp
ALGNAlign Technology, Inc.LTM Jun 202610.0% -1.0 pp+0.5 pp
HSICHenry Schein, Inc.LTM Jun 20263.0% -0.1 pp-1.2 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-17.1% +7.4 pp+8.0 pp
Peer median (excluding XRAY) 10.0%-0.1 pp-1.2 pp

Competitors are the stored peer set for XRAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.23B3.92B3.97B3.79B3.68B
Cost of Revenue1.88B1.8B1.88B1.84B1.84B
Gross Profit2.35B2.13B2.09B1.96B1.84B
Gross Margin55.5%54.2%52.6%51.6%50.0%
Research & Development171M174M184M165M150M
Selling, General & Admin1.55B1.59B1.61B1.61B1.44B
Operating Expenses1.74B3.06B2.17B2.84B1.59B
Depreciation & Amortization346M328M343M349M352M
EBITDA952M(662M)249M(518M)(46M)
EBITDA Margin22.5%-16.9%6.3%-13.7%-1.3%
Operating Income608M(937M)(85M)(879M)252M
Operating Margin14.4%-23.9%-2.1%-23.2%6.8%
Interest Income00000
Interest Expense61M65M81M69M88M
Other Income / Expenses(63M)(118M)(90M)(57M)(738M)
Income Before Tax545M(1.06B)(175M)(936M)(486M)
Pre-Tax Margin12.9%-26.9%-4.4%-24.7%-13.2%
Income Tax Expense134M(105M)(43M)(26M)112M
Net Income411M(950M)(132M)(910M)(598M)
Net Margin9.7%-24.2%-3.3%-24.0%-16.3%
EPS (Basic)1.88(4.41)(0.62)(4.48)(3.00)
EPS (Diluted)1.87(4.41)(0.62)(4.48)(3.00)
Weighted Avg Shares218.4M215.5M212M203.2M199.4M
Weighted Avg Shares (Diluted)220.2M215.5M212M203.2M199.4M

DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Intrinsic Alpha fair value

Locked

Current Price

$8.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.